Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
ALBUQUERQUE, NM and SAN DIEGO, CA, Oct. 31, 2017 -- Exagen Diagnostics will feature 5 presentations highlighting the usefulness of AVISE® testing at the American College of Rheumatology’s (ACR/ARHP) annual meeting being held Nov. 5-7, 2017 in San Diego, CA. The AVISE family of tests includes AVISE CTD featuring patented cell-bound complement activation products (CB-CAPS) with enhanced detection for certain autoimmune rheumatic diseases including systemic lupus erythematosus (SLE). Attendees are invited to visit the Exagen exhibit #1713 to learn more about the benefits of AVISE testing, including the new AVISE SLE Monitor test. Abstracts can be seen online at the ACR website http://acrabstracts.org Titles, presentation dates and abstract numbers for the five featured posters are listed below.
|
|||
Sunday November 5, 2017 Cell Bound Complement Activation Products Distinguish Systemic Lupus Erythematosus from other diseases among patients with high Antinuclear Antibody Titers and Normal Complement
Presented by Dr. Daniel J. Wallace
Abnormalities in Complement System are Related to Disease Severity Index in Systemic Lupus Erythematosus (SLE)
Presented by Cristina Arriens
A Panel of Lupus Biomarkers for the Monitoring of Systemic Lupus Erythematosus: Performance Characteristics in Distinct SLE Cohorts
Presented by Dr. Joan T. Merrill
Complement Activation in Peripheral Blood in Relation to Lupus, Antiphospholipid and Rheumatoid Arthritis Autoantibodies: Insights from Clinical Laboratory Evaluations
Presented by Thierry Dervieux
Tuesday November 7, 2017
Cell-Bound Complement Activation Products as Markers of Disease Flares in Childhood Onset Systemic Lupus Erythematosus.
Presented by Yevgeniya Gartshteyn
About Exagen
Exagen Diagnostics, Inc. is a College of American Pathologists (CAP) accredited and CLIA certified rheumatology specialty laboratory that focuses on the significant unmet need for accurate and timely diagnosis, prognosis and monitoring of autoimmune connective tissue diseases (CTD). Its groundbreaking solutions address the full continuum of care with tools designed and clinically shown to help physicians deliver accurate, early diagnosis and optimized therapy. For more information, visit www.AviseTest.com
About Lupus and Rheumatoid Arthritis
Lupus and rheumatoid arthritis are autoimmune diseases in which the body attacks its own, healthy tissues and organs. Patients suffer joint pain along with increased risk for other life threatening conditions. Systemic Lupus Erythematosus (SLE), a more severe form of lupus brings with it a host of unwanted symptoms including unexplained fevers, hair loss, fatigue, and skin rashes. Women are more likely to suffer from these conditions than men, and there’s no definitive cause, though researchers suspect genes as well as environmental factors may play a role.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/52cde2e4-6da9-4b91-9583-ba444c97aee2
Brian McEvilly Exagen Diagnostics, Inc. 858-736-5517 [email protected]
